Industry and government leaders to analyse EU medical device regulations
6 May 2006
Rockville, Md., USA. Top-level European government and industry leaders
will join together to dissect European policy on health product innovation
at a June regulatory affairs conference in Portugal.
Rui Santos-Ivo, Enterprise and Industry Directorate-General, European
Commission; Maurice Wagner, Director General, EUCOMED; Anthony Humphreys,
Head of Sector, RA and Organisational Support, EMEA; and Karima Boubekeur,
head of External R&D Policy, F. Hoffmann-La Roche AG, will be featured in a
panel at the Regulatory Affairs Professionals Society (RAPS) European
Conference, 1-2 June 2006, Sana Lisboa Hotel, Lisboa, Portugal.
The panelists, all prominent in their fields, will focus on medicinal
product and medical device sector policies that address the European
initiative to promote innovation and enhance technology. These and other
experts will also evaluate the role of innovation in growth of research and
development and the commission's future policy proposals.
"This is a crucial opportunity for European industry and government
leaders to evaluate how health product regulations can continue to advance
health," said RAPS Executive Director Sherry L. Keramidas, PhD, CAE. "It is
vital for regulatory professionals from industry, government and research to
participate in discussions on the rapid evolution of scientific research,
the health product industries and regulation."
RAPS' European Conference, started in 1995, is a leading venue for health
product regulatory affairs professionals to address changes in the European
and worldwide regulatory environments, affecting medical devices, IVDs,
pharmaceuticals, biologics and combination products. This year's conference
topics include the Medical Devices Directive, EU Pharmaceutical Legislation,
Paediatric Regulation, EMEA's EU Risk Management Plan and Clinical
The conference also features Margaret Murphy, of Patients for Patient
Safety, part of WHO World Alliance for Patient Safety. Murphy will highlight
the role patients and patient advocates must play in interactions with
healthcare systems and in partnerships with health professionals and policy-
"Regulatory Affairs professionals play a critical role in ensuring that
products are safe and beneficial to patients," Keramidas said.
For more information or to register for the conference, visit the RAPS